A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIRTM) in the management of atopic dermatitis in paediatric patients-Reference-Cited by-同舟云学术

A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIRTM) in the management of atopic dermatitis in paediatric patients

Published:2008-02-20 Issue:0 Volume:0 Page:080220191244231-???
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatr Allergy Immunol

Author:

Patrizi Annalisa,Capitanio Bruno,Neri Iria,Giacomini Federica,Sinagra Jo L.,Raone Beatrice,Berardesca Enzo

Publisher

Wiley

Subject

Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3038.2008.00724.x/fullpdf

Reference19 articles.

1. Atopic dermatitis in infancy and childhood: an ongoing challenge

2. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use

3. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

4. The use of topical calcineurin inhibitors in dermatology: Safety concerns

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A quantitative systems pharmacology workflow toward optimal design and biomarker stratification of atopic dermatitis clinical trials;Journal of Allergy and Clinical Immunology;2024-05

2. Topical Treatments in Atopic Dermatitis: An Expansive Review;Journal of Clinical Medicine;2024-04-10

3. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials;Journal of Allergy and Clinical Immunology;2023-12

4. A quantitative systems pharmacology workflow towards optimal design and biomarker stratification of atopic dermatitis clinical trials;2023-07-03

5. How and what adverse events are reported and captured in randomized control trials of emollients in the treatment of eczema?;Clinical and Experimental Dermatology;2023-04-19